1. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel, and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (M.S.)
2. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (N.J.)
3. Department of Medicine and Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California (G.M.C.)
4. Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (O.M.)
5. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (J.J.V.M.)
6. The National Medical Science and Nutrition Institute Salvador Zubiran, Mexico City, Mexico (R.C.)
7. Steno Diabetes Center Copenhagen, Gentofte, Denmark, and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark (P.R.)
8. Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., C.D.S.)
9. Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas (R.D.T.)
10. Department of Renal Medicine, University College London, London, United Kingdom (D.C.W.)
11. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, and The George Institute for Global Health, Sydney, New South Wales, Australia (H.J.L.H.).